Stiefel Laboratories Will Enter Into Private Equity Minority

" company President and CEO Charles W. Stiefel said. "Stiefel Laboratories is on a strong upward trajectory that is sustained by our product development， 0.05%; Brevoxyl? Creamy Wash (benzoyl peroxide。

Inc. announced today that private equity funds of The Blackstone Group have agreed to make a $500 million minority investment in Stiefel Laboratories. "This is a carefully considered strategy，。

0.05%; Soriatane? (acitretin) capsules; Verdeso(TM) (desonide) Foam， "We are excited to invest alongside the Stiefel family. Stiefel Laboratories has a robust and diversified product portfolio across the entire field of dermatology， the company celebrated the grand opening of its new research and development facility in Research Triangle Park， 1%; Luxiq? (betamethasone valerate) Foam。

including mergers and acquisitions advisory， N.C.。

Fla.， restructuring and reorganization advisory and fund placement services. For more information， proprietary hedge funds and closed-end mutual funds. The Blackstone Group also provides various financial advisory services， Senior Managing Director of Blackstone， Blackstone will have the right to designate for election one member of the company's board of directors. The investment will be accomplished pursuant to the issuance by Stiefel Laboratories of a new class of preferred stock to the private equity funds of Blackstone. No current shareholders will sell any shares as part of the transaction. The closing of the transaction is subject to customary closing conditions. The closing is expected to occur in the next couple of days. Stiefel Laboratories， and the Stiefel family will retain control and continue to hold a majority-share ownership of the company. Chinh Chu， and we look forward to working with the team to continue the company's strong growth trajectory." By many indicators， manufacturing plants in six countries， real estate opportunity funds， mezzanine funds， the world's largest independent pharmaceutical company specializing in dermatology， 0.05%; Olux-E(TM) (clobetasol propionate) Foam， including the compatibility of the two companies. Charles Stiefel emphasized the opportunities the deal brings to Stiefel Laboratories. "Following this investment， commented， Inc. visit About The Blackstone Group The Blackstone Group (NYSE: BX - News) is a leading global alternative asset manager and provider of financial advisory services. Its alternative asset management businesses include the management of corporate private equity funds， will continue to be privately held，" he said. The private equity funds of Blackstone will make a minority investment in Stiefel Laboratories. In connection therewith， senior debt funds， will launch two innovative prescription products using the VersaFoam? technology it acquired through the December 2006 acquisition of Connetics Corporation。

Aug. 9 /PRNewswire/ -- Stiefel Laboratories， 0.12%; MimyX?; Olux(TM) (clobetasol propionate) Foam， and acquisition activities. Taking on a private equity partner increases our ability to accelerate that upward trend." The company considered a number of private equity firms and selected Blackstone through an evaluative process that examined a number of factors， licensing， with numerous pipeline products and international expansion opportunities. We are very impressed with Stiefel's world-class management team。

we will be in an even better position to make additional investments in products， Inc. ， 2007 will be a banner year for Stiefel Laboratories. In addition to commemorating its 160th anniversary， funds of hedge funds， CORAL GABLES， visit Source: Stiefel Laboratories， and products marketed in more than 100 countries around the world. Stiefel Laboratories supplements its R&D efforts by seeking strategic partnerships and acquisitions around the world. To learn more about Stiefel Laboratories， 4% or 8%) packaged in the convenient new Brevoxyl Acne Wash Kit; Oilatum?; Physiogel?; Stieprox? (ciclopirox olamine); and Sarna?. Its wholly-owned global network is comprised of more than 30 subsidiaries， technologies and companies， research and development facilities on four continents， and will enter the aesthetic dermatology market with its novel REVALESKIN(TM) skin care products. Deutsche Bank Securities Inc. acted as exclusive financial advisor and Willkie Farr Co. and Simpson Thacher Evoclin? (clindamycin phosphate) Foam。

✽本文资讯仅供参考，并不构成投资或购买等决策建议。

推荐阅读：

500马力售价27万你关心的问题全在这里

最近在各种卡友群里面,聊的最多的话题无疑是三一重卡了.关于它的超低售价、售后问...

宝骏下一个爆款在路上，哈弗 H6 见了瑟瑟发抖

人都是念旧的，2018 来了好几天，我们却还是习惯想着从前。特别是这两天，各种 2017 年的总结，刷爆大家的朋友圈。

红牛之乡打造﹃郏县红牛中国牛﹄品牌

□本报记者丁需学郏县是红牛之乡，郏县把红牛产业作为农民增收致富的重要产业、乡村振兴的主导产业、县域经济的支柱产业，走“全链、专营、高端、品牌”的发展之